Randomized clinical trial of post-operative radiotherapy versus concomitant carboplatin and radiotherapy for head and neck cancers with lymph node involvement.
暂无分享,去创建一个
G. Calais | F. Baillet | M. Housset | C. Hennequin | C. Durdux | M. Henry-Amar | R. Bensadoun | P. Géhanno | J. Mazeron | S. Racadot | M. Mercier | G. Pillet | V. Favrel | S. Dussart | E. Malaurie | Michel Martin | E. Haddad | C. Diana | B. Dessard-Diana | J. Huet | C. Journel | Brigitte Blaska-Jaulerry
[1] R. Gilbert,et al. Postoperative chemoradiotherapy for advanced squamous cell carcinoma of the head and neck: A systematic review with meta‐analysis , 2007, Head and Neck.
[2] L. Wilson,et al. Postoperative Concurrent Chemoradiotherapy with Mitomycin in Advanced Squamous Cell Carcinoma of the Head and Neck: Results from Three Prospective Randomized Trials , 2006, Cancer journal.
[3] M. van Glabbeke,et al. Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) , 2005, Head & neck.
[4] J. Jacobs,et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. , 2004, The New England journal of medicine.
[5] Jacques Bernier,et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. , 2004, The New England journal of medicine.
[6] J. Pignon,et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta analysis of chemotherapy on head and neck cancer , 2001 .
[7] J. Bourhis,et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data , 2000, The Lancet.
[8] G. Calais,et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. , 1999, Journal of the National Cancer Institute.
[9] K. Ang,et al. Precisely defining high‐risk operable head and neck tumors based on rtog #85‐03 and #88‐24: Targets for postoperative radiochemotherapy? , 1998, Head & neck.
[10] B. Jeremic,et al. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial. , 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[11] E. Cohen-Jonathan,et al. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. , 1996, International journal of radiation oncology, biology, physics.
[12] J. Pignon,et al. Meta-analysis of chemotherapy in head and neck cancer: individual patient data vs literature data. , 1995, British Journal of Cancer.
[13] T. Pajak,et al. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) , 1995, International journal of radiation oncology, biology, physics.
[14] H. Eckel,et al. [Cisplatin/5-FU versus carboplatin/5-FU. 5 year follow-up]. , 1994, HNO.
[15] Icru. Prescribing, recording, and reporting photon beam therapy , 1993 .
[16] A S Garden,et al. Evaluation of the dose for postoperative radiation therapy of head and neck cancer: first report of a prospective randomized trial. , 1993, International journal of radiation oncology, biology, physics.
[17] S. Rockwell,et al. Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials. , 1993, International journal of radiation oncology, biology, physics.
[18] B. Qaqish,et al. Simultaneous chemoradiation in the treatment of advanced head and neck cancer. , 1992, Archives of otolaryngology--head & neck surgery.
[19] L. Peters,et al. Resection of advanced cervical metastasis prior to definitive radiotherapy for primary squamous carcinomas of the upper aerodigestive tract , 1992, Head & neck.
[20] R. Crooijmans,et al. Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin: influence of treatment sequence. , 1991, International journal of radiation oncology, biology, physics.
[21] J. Jacobs,et al. Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73-03. , 1991, International journal of radiation oncology, biology, physics.
[22] R. Crooijmans,et al. Effectiveness of cis-platin and carboplatin in the chemotherapy of squamous cell carcinoma grown as multicellular spheroids. , 1990, Anticancer research.
[23] S. Rockwell,et al. Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. , 1989, International journal of radiation oncology, biology, physics.
[24] D. Ettinger,et al. Ifosfamide in the treatment of non-small cell lung cancer. , 1989, Seminars in oncology.
[25] C. Coughlin,et al. Biologic and clinical developments of cisplatin combined with radiation: concepts, utility, projections for new trials, and the emergence of carboplatin. , 1989, Seminars in oncology.
[26] R. Gelber,et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. , 1987, Head & neck surgery.
[27] E. Douple,et al. Carboplatin as a potentiator of radiation therapy. , 1985, Cancer treatment reviews.
[28] A. Hart,et al. Prognostic factors of neck node metastasis. , 1982, Clinical otolaryngology and allied sciences.
[29] H. Bartelink,et al. Radiotherapy of lymph node metastases in patients with squamous cell carcinoma of the head and neck region. , 1982, International journal of radiation oncology, biology, physics.
[30] L. Freedman. Tables of the number of patients required in clinical trials using the logrank test. , 1982, Statistics in medicine.
[31] N. Mantel. Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.
[32] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[33] D.,et al. Regression Models and Life-Tables , 2022 .